Product image of Mucofree (Ambroxol Hydrochloride) supplied by GNH India

Mucofree

Active Ingredient:
Ambroxol Hydrochloride
Origin:
EU

Mucofree (Ambroxol Hydrochloride)

Ambroxol Hydrochloride, the active ingredient in Mucofree, is a mucolytic presented as an oral formulation for systemic use. It helps to reduce the viscosity of respiratory tract secretions and is employed in the management of acute and chronic bronchial conditions where mucus hypersecretion impairs breathing.

GNH India supplies Mucofree as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Opella Healthcare Commercial Kft.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ambroxol Hydrochloride acts on the respiratory mucosa to facilitate clearance of thick secretions, making it useful in several airway disorders.

  • Acute bronchitis: improves cough productivity by thinning mucus.
  • Chronic bronchitis: reduces mucus thickness and eases expectoration.
  • Chronic obstructive pulmonary disease (COPD): supports mucociliary clearance during exacerbations.
  • Asthma with mucus hypersecretion: assists in clearing airway secretions.
  • Upper respiratory tract infections: alleviates congestion by decreasing mucus viscosity.

How It Works

  • Ambroxol Hydrochloride stimulates serous cells in the respiratory epithelium, increasing the production of watery secretions. This reduces the viscosity of mucus, enhances ciliary activity, and promotes more effective mucociliary clearance, thereby facilitating the removal of airway secretions and improving ventilation.

Side Effects

Adverse reactions may occur with Ambroxol Hydrochloride and are categorized by frequency.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Vomiting: occasional episodes after dosing.
  • Taste disturbance: metallic or bitter taste in the mouth.
  • Abdominal discomfort: mild cramps or pain.
  • Diarrhea: loose stools in some patients.
  • Headache: transient mild headache.

Serious or Rare Side Effects

  • Allergic reactions: rash, pruritus, or urticaria.
  • Angioedema: swelling of face, lips, or tongue.
  • Severe skin reactions: Stevens‑Johnson syndrome.
  • Hepatic enzyme elevation: rare liver function abnormalities.
  • Anaphylaxis: life‑threatening hypersensitivity.
  • Eosinophilia: elevated eosinophil count in blood.

Precautions & Warnings

When prescribing Ambroxol Hydrochloride, consider the following safety measures.

  • Assess renal function: adjust use in severe renal impairment.
  • Monitor hepatic status: use cautiously in liver disease.
  • Watch for hypersensitivity: discontinue if allergic signs appear.
  • Avoid in known ambroxol allergy: contraindicated for patients with prior reactions.
  • Pregnancy: consult a physician before use; safety data are limited.
  • Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Avoid Interactions

Ambroxol Hydrochloride may interact with other medicines; awareness of interaction severity is essential.

Major Interactions (Avoid)

  • Concurrent use with other mucolytics: may increase gastrointestinal irritation.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise ambroxol plasma levels.
  • Anticholinergic agents: may diminish mucociliary clearance benefits.

Moderate Interactions (Monitor Closely)

  • Aminoglycoside antibiotics: monitor renal function due to combined nephrotoxic potential.
  • NSAIDs: may exacerbate gastrointestinal upset.
  • Alcohol: can enhance dizziness or drowsiness.
  • Bronchodilators: observe for possible bronchospasm in sensitive individuals.

Frequently Asked Questions

Mucofree contains Ambroxol Hydrochloride, which is used to thin and loosen thick mucus in the airways. It is indicated for acute and chronic bronchitis, chronic obstructive pulmonary disease (COPD), asthma with mucus hypersecretion, and upper respiratory tract infections where excessive mucus impairs breathing.

Ambroxol stimulates serous cells in the respiratory epithelium, increasing the secretion of watery fluid. This reduces mucus viscosity, enhances ciliary movement, and promotes more efficient clearance of secretions from the airways, helping to relieve cough and improve ventilation.

The appropriate dose of Mucofree is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and overall health status. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for Ambroxol Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Mucofree.

To place an order, submit an enquiry on the Mucofree product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mucofree’s active ingredient, Ambroxol, is a well‑studied mucolytic that increases serous secretion and improves mucociliary clearance. Compared with other agents such as carbocisteine or N‑acetylcysteine, Ambroxol often has a faster onset of action and may be better tolerated, though choice depends on individual patient factors and physician preference.

Mucofree should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Mucofree is taken orally, usually with a glass of water. The tablet or liquid should be swallowed whole and not chewed, unless the specific dosage form instructions indicate otherwise. Follow the prescribing clinician’s guidance regarding timing relative to meals.

Serious adverse reactions, though rare, can include severe allergic responses such as rash, angioedema, Stevens‑Johnson syndrome, anaphylaxis, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience any signs of a severe hypersensitivity reaction.

Mucofree should be avoided in individuals with a known hypersensitivity to Ambroxol Hydrochloride or any of the product’s excipients. It is also contraindicated in patients who have experienced severe allergic reactions to other mucolytic agents.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ambroxol Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT